In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017

Oct 25, 2013, 10:50 ET from Research and Markets

DUBLIN, October 25, 2013 /PRNewswire/ --

Research and Markets ( has announced the addition of the "In Vitro Diagnostic (IVD) Market, Technique & Applications - Forecast To 2017" report to their offering.

     (Logo: )

The global in vitro diagnostics market was valued at $49.2 billion in 2012. The factors likely to fuel the growth of the market include on-going developments in analytical laboratory automation, swift progress in various fields of diagnosis such as point-of-care testing, molecular diagnosis, immunoassays, hematology, flow cytometry, microbiology and finally, the geographical market expansion within emerging countries.

The most important trend witnessed recently in the in vitro diagnostic industry is that of self-testing as opposed to patients visiting hospitals. This is one of the biggest factors responsible for the growth of point-of-care testing, as patients prefer self-testing to avoid unnecessary visits to the hospital. However, factors such as stringent regulatory frameworks and a shortage of budget are restraining the growth of this market.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global In Vitro Diagnostic Market, By Technique

5 Global In Vitro Diagnostic Market, By Product Type
5.1 Introduction
5.2 Instruments
5.3 Reagents
5.4 Data Management System Software/Hardware
5.5 Services

6 Global In Vitro Diagnostic Market, By Application
6.1 Introduction
6.2 Diabetes
6.3 Infectious Diseases
6.4 Oncology/Cancer
6.5 Cardiology
6.6 Nephrology
6.7 Autoimmune Diseases
6.8 Drug Testing
6.9 HIV/Aids
6.10 Others

7 Global In Vitro Diagnostic Market, By End-User
7.1 Introduction
7.2 Laboratory
7.3 Hospitals
7.4 Academics
7.5 Point-Of-Care Testing
7.6 Patient Self-Testing
7.7 Others

8 Geographic Analysis

9 Competitive Landscape

10 Company Profiles (Overview, Financials, Products & Services, Developments & Strategy)*

Companies Mentioned

  • Abbott Laboratories, Inc
  • Alere, Inc
  • Arkray, Inc
  • Bayer AG
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc
  • Biomerieux
  • Danaher Corporation
  • Diagnostica Stago Sas
  • Diasorin SPA
  • Hologic, Inc
  • Horiba, Ltd
  • Johnson & Johnson
  • Novartis International Ag
  • Qiagen NV
  • Roche Diagnostics Limited
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics

SOURCE Research and Markets